| CXSS2100031 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-03-26 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | Certificate Completed-Pending Issued | 2021-12-10 | view |
| CXSS2100032 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-03-26 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | Certificate Completed-Pending Issued | 2021-12-10 | view |
| CYSB2100072 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | Supplementary Application | 2021-03-19 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-03-18 | view |
| CXSB2100017 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2021-03-12 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-03-11 | view |
| CXSL2100079 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-03-03 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-03-02 | view |
| CXSL2100080 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-03-03 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-03-02 | view |
| CXSL2100042 | SHR-1314注射液 | vunakizumab | Injection | Biological Products(1) | New Drug Application | 2021-02-03 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-02-03 | view |
| CXSL2100018 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-01-19 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-01-19 | view |
| CXSL2100017 | SHR-1701注射液 | retlirafusp alfa | Injection | Biological Products(1) | New Drug Application | 2021-01-19 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-01-19 | view |
| CXSB2000173 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | Supplementary Application | 2021-01-05 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-01-04 | view |
| CXSL2000366 | SHR-1701注射液 | retlirafusp alfa | Injection | Biological Products(1) | New Drug Application | 2020-12-18 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-12-17 | view |
| CXSB2000134 | SHR-1701注射液 | retlirafusp alfa | Injection | Biological Products(1) | Supplementary Application | 2020-12-14 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-12-11 | view |
| CXSB2000116 | SHR-1314注射液 | vunakizumab | Injection | Biological Products(1) | Supplementary Application | 2020-12-02 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-12-01 | view |
| CXSS2000055 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2020-11-12 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-11-11 | view |
| CXSL2000300 | SHR-1701注射液 | retlirafusp alfa | Injection | Biological Products(1) | New Drug Application | 2020-10-27 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-10-26 | view |
| CXSL2000298 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2020-10-27 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-10-26 | view |
| CXSL2000301 | SHR-1701注射液 | retlirafusp alfa | Injection | Biological Products(1) | New Drug Application | 2020-10-27 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-10-26 | view |
| CXSB2000050 | SHR-1222注射液 | SHR-1222 | Injection | Biological Products(1) | Supplementary Application | 2020-09-05 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-09-04 | view |
| CXSS2000045 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2020-09-04 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-09-03 | view |
| CXSL2000254 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2020-09-04 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-09-03 | view |
